Key Trends Shaping the Enteral Feeding Formulas Market
The report "Enteral Feeding Formulas Market by Product (Polymeric, Elemental, Disease-specific), Stage (Adults, Pediatrics), Application (Oncology, Gastroenterology, Neurology, Hypermetabolism), End User (Hospitals, LTCF, Home care) - Global Forecast to 2027", is projected to reach USD 8.2 billion by 2027 from USD 5.2 billion in 2022, growing at a CAGR of 9.5% during the forecast period. Factors such as benefits of enteral nutrition over parenteral nutrition, increase in cost for healthcare expensis, rise in the number of preterm births, growing population of gerartric patients, increased prevalence of chronic diseases such as GI disorders, neurological disorders, Diabetses, etc., increased awareness of enteral nutrition in emerging countries are expected to improve market growth. However, rising cases of feeding and medication errors and underfeeding; and the complications associated with lack of skilled proffesionals are restricting the growth of this market to a certain extent. Also, insufficient or lack of reimbursements in some developing and underdeveloped countries and a dearth of trained physicians across the globe pose significant challenges for the growth of this market.